GlassScriptPhysician profile
Logan Noah Lipsch
NPI 1679344592
$2,064.76
in general payments reported to CMS, 2019-2025
18 companies · $610 in 2025
The $610 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,455 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275 · Travel and Lodging: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.53 |
| Travel and Lodging | $790.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,174.43 | 2024-2025 | Minimed 780g |
| Lilly USA, LLC | $157.97 | 2024 | Mounjaro, Jardiance |
| Novo Nordisk INC | $113.63 | 2024-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $94.67 | 2024-2025 | |
| Abbott Laboratories | $64.88 | 2025 | Freestyle Libre 3, Proclaim |
| Insulet Corporation | $64.47 | 2024-2025 | Omnipod |
| Dexcom, INC. | $58.69 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.79 | 2025 | Jardiance |
| Corcept Therapeutics | $53.87 | 2024-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $43.82 | 2024-2025 | |
| Amgen INC. | $31.82 | 2024 | Prolia, Evenity |
| Recordati_rare_diseases_inc. | $30.71 | 2025 | Isturisa |
| Beta Bionics, INC. | $23.79 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Phathom Pharmaceuticals, INC. | $20.48 | 2024 | Voquezna |
| Amneal Pharmaceuticals LLC | $19.93 | 2024 | Unithroid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $19.25 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $18.48 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Radius Health, INC. | $18.08 | 2025 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Lipsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.